Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer

Genes Chromosomes and Cancer

Volumn 21, Issue 3, 1998, Pages 244-249

  Greenman, Jill ^a   Mohammed, Shehla ^a   Ellis, David ^a   Watts, Sally ^a   Scott, Gillian ^a   Izatt, Louise ^a   Barnes, Diana ^b   Solomon, Ellen ^a   Hodgson, Shirley ^a   Mathew, Christopher ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODUPLEX;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CARBOXY TERMINAL SEQUENCE; FAMILIAL CANCER; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GERM LINE; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; OVARY CANCER; PRIORITY JOURNAL; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

EID: 0031905512     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2264(199803)21:3<244::aid-gcc9>3.0.co;2-%23     Document Type: Article

References (24)

1. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T (1997) The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60:505-514.
2. Beundet AL, Tsui LC (1993) A suggested nomenclature for designating mutations. Hum Mutat 2:245-248.
3. Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Eshano ML, Brody LC, Collins FS, Weber BL (1994) Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 8:387-391.
4. Chapman MS, Verma IM (1996) Transcriptional activation by BRCA1. Nature 382:678-679.
5. Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324.
6. Couch FJ, Weber BL, Breast Cancer Information Core (1996) Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum Mutat 8:8-18.
7. Durocher F, Shattuck-Eidens D, McClure M, Labrie F, Skolnick MH, Goldgar DE, Simard J (1996) Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum Mol Genet 5:835-842.
8. Fitzgerald MO, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA (1996) Germ-line mutations in Jewish and non-Jewish women with early-onset breast cancer. New Engl J Med 334:143-149.
9. Ford D, Easton DF, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457-1462.
10. Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King M-C (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8:399-404.
11. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigan S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122.
12. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington P, Chian M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, Love R, Evans G, Easton D, Clayton D, Stratton MR, Ponder BAJ (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 11:428-133.
13. Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF, Ponder BAJ (1996) Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. Am J Hum Genet 58:451-456.
14. Grompe M (1993) The rapid detection of unknown mutations in nucleic acids. Nat Genet 5:111-117.
15. Haliassos A, Chomel J, Tesson A, Baudis M., Kruh J, Kaplan JC, Kitzis A (1989) Modification of enzymatically amplified DNA for the detection of point mutations. Nucl Acids Res 17:3606.
16. Hayashi K, Yandell DW (1993) How sensitive is PCR-SSCP? Hum Mutat 2:338-346.
17. Ithier G, Girard M, Stoppa-Lyonnet D (1996) "Definite" mutations in the BRCA1 gene. New Engl J Med 334:1198-1199.
18. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA (1996) BRCA1 mutations in a population-based sample of young women with breast cancer. New Engl J Med 334:137-142.
19. Miki Y, Swensen J, Shattuck-Eidens D, Futreal A, Harshman K, Tavtigan S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frue C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
20. Monteiro AN, August A, Hanafusa H (1996) Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci USA 93:13595-13599.
21. Rowley G, Saad S, Giannelli F, Green PM (1996) Ultrarapid mutation detection by multiplex, solid phase chemical cleavage. Genomics 30:574-582.
22. Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pages S, Ithier G, Ligot LK, Eourquet A, Salmon RJ, Clough KB, Pouillart P, the Institut Curie Breast Cancer Group, Bonaiti-Pellie C, Thomas G (1997) BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Am J Hum Genet 60:1021-1030.
23. Stratton MR (1996) Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet 5:1515-1519.
24. Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013-1020.